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Background
Recapitulating immunodominant A2-restricted HIV-spe-
cific CTLs that do not suppress virus in vivo is unlikely to
be an effective vaccine strategy.
Methods
To detect novel subdominant determinants in HIV-1 Gag,
we primed CD8+ T cells from eight seronegative donors
with autologous dendritic cells transduced to express Gag.
T cells were re-stimulated weekly with monocytes pulsed
with 123 15-mer overlapping peptides (OLPs) spanning
Gag. Responses were identified with OLP matrix pools fol-
lowed by interrogation at the single OLP level in respon-
sive pools using IFN-γ ELISPOT assays.
Results
One OLP (Gag145-159) was recognized by all donors. Of
note, this reactivity predominated in five of eight T cell
cultures. Fine mapping with progressively truncated pep-
tides revealed three overlapping epitopes: RTLNAWVKV
(RV9), RTLNAWVKVV (RV10) and TLNAWVKVV (TV9).
TV9 is a known epitope that is rarely recognized in vivo. In
contrast, RV9 and RV10 are novel. Although the latter
bound with lower affinities to HLA-A2 than TV9, RV9-
and RV10-cultures were readily generated. RV9- and
RV10-T cells were cytotoxic, secreting cytokines and sup-
pressive of HIV replication in vitro.
Conclusion
In sum, we report two novel naturally processed and pre-
sented epitopes in HIV p24 that are recognized by pre-
infection T cell repertoires. Further studies are needed to
explain why these reactivities are rare during infections
and more importantly, whether this conserved region of
the HIV proteome has value as a prophylactic vaccine for
A2 individuals.
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